CVS Health Corp vs Kraft Heinz Co — how do they compare? CVS Health Corp trades at $86.85 (market cap $112.49B), while Kraft Heinz Co trades at $22.51 (market cap $26.06B). The key difference: CVS Health Corp is far larger — about 4.3× Kraft Heinz Co's market cap, and Kraft Heinz Co pays the higher dividend (7.28%). Which is the better fit depends on your goals — on Pluang, investors hold CVS Health Corp for 83 Days and Kraft Heinz Co for 129 Days on average.
| CVS | KHC | |
|---|---|---|
Market Cap | $112.49B | $26.06B |
Volume | 8,467,392 | 15,326,651 |
Sector | Health | Consumer Staples |
52-Week High | $110.60 | $27.62 |
52-Week Low | $70.08 | $21.21 |
Typical Hold Time | 83 Days | 129 Days |
Enterprise Value | $174.83B | $42.38B |
Dividend Yield | 3.02% | 7.28% |
Signals from Pluang's Aura AI — not financial advice
CVS Health trades at $87.80, up 1.59% today, with strong analyst support (85% buy ratings) and a $111.20 consensus price target suggesting 27% upside. Recent quarterly earnings have consistently beaten expectations, with Q2 2026 EPS of $2.58 surpassing the $1.87 estimate. Revenue growth remains solid, reaching $402.07B in 2025, though net margins compressed to 1.18%. The technical picture shows bullish momentum with current price near key support at $87.
CVS presents a compelling value opportunity with attractive valuation multiples (P/E 23.21, P/S 0.27) and dividend stability, but faces margin pressure from healthcare cost trends. The stock's upside depends on maintaining earnings momentum amid reimbursement challenges and regulatory scrutiny highlighted in recent legal investigations.
Kraft Heinz (KHC) trades at $22.48, up 2.04% today, with a bearish technical signal but recent earnings beats. The stock shows a low P/E of 13.04 and P/B of 0.72, yet profitability is weak with a -13.64% net margin. Cash flow improved to $1.46B in 2025, but a $5.85B net loss and high debt of $19.22B pose challenges. News highlights dividend stability and brand revitalization efforts, such as new Philadelphia cream cheese flavors.
Outlook remains cautious; the stock offers value with a dividend yield near 6%, but turnaround success is critical. Risks include sustained volume declines and debt servicing. Analysts are mixed with a $23.78 consensus target, suggesting limited upside. Institutional interest exists, but weak fundamentals warrant careful monitoring for recovery signs.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Following its acquisition of Aetna in late 2018, CVS Health now provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing over 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with 24 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.
Read more on CVS →In July 2015, Kraft merged with Heinz to create the third-largest food and beverage manufacturer in North America behind PepsiCo and Nestle and the fifth-largest player in the world. Beyond its namesake brands, the combined firm's portfolio includes Oscar Mayer, Velveeta, and Philadelphia. Outside North America, the firm's global reach includes a distribution network in Europe and emerging markets that drive around one fifth of its consolidated sales base, as its products are sold in more than 190 countries and territories.
Read more on KHC →